Tag: EGFR,In the News,NSCLC,Non-Small Cell Lung Cancer,Pharma,Veristrat,biomarker,liquid biopsy,lung cancer,molecular diagnostic,oncology,personalized medicine,pharmaceutical
-
Biodesix Targeting Pharma for VeriStrat (GenomeWeb)
As Biodesix continues clinical validation and commercialization of its test to predict patient response to therapies for non-small cell lung cancer, it is looking to forge pharmaceutical partnerships to increase adoption of the test. The company is in the midst of conducting a trial in Italy to determine whether the test can determine which NSCLC…